Letter to editor: effects of vancomycin in primary sclerosing cholangitis with and without inflammatory bowel disease

Authors

Sheza Malik, Rochester Regional HealthFollow
Priyadarshini Loganathan, Gastroenterology, The University of Texas Health Science Center at San Antonio, San Antonio, TX, USA.
Babu P. Mohan, Gastroenterology & Hepatology, Orlando Gastroenterology PA, Orlando, FL, USA.

Department

Internal Medicine

Document Type

Article

Publication Title

Scandinavian Journal of Gastroenterology

First Page

630

DOI

10.1080/00365521.2024.2310168

Volume

59

Issue

5

Publication Date

5-1-2024

Medical Subject Headings

Humans; Cholangitis, Sclerosing (drug therapy, complications); Vancomycin (adverse effects, therapeutic use); Anti-Bacterial Agents (therapeutic use, adverse effects); Inflammatory Bowel Diseases (drug therapy, complications); Female; Male; Middle Aged; Adult

PubMed ID

38289040

Recommended Citation

Malik, S., Loganathan, P., & Mohan, B. P. (2024). Letter to editor: effects of vancomycin in primary sclerosing cholangitis with and without inflammatory bowel disease. Scandinavian Journal of Gastroenterology, 59 (5), 630. https://doi.org/10.1080/00365521.2024.2310168